|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.72 INR | -0.54% |
|
+0.32% | -11.55% |
| Market Cap | 978M 10.27M 8.98M 8.25M 7.69M 14.58M 14.8M 99.02M 38.49M 481M 38.54M 37.71M 1.66B | P/E 2024 |
10.4x | P/E 2025 | 11.2x |
|---|---|---|---|---|---|
| Enterprise Value | -149M -1.57M -1.37M -1.26M -1.17M -2.23M -2.26M -15.12M -5.88M -73.39M -5.89M -5.76M -253M | EV / Sales 2024 |
0.81x | EV / Sales 2025 | 0.94x |
| Free-Float |
42.71% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.54% | ||
| 1 week | +0.32% | ||
| Current month | +1.73% | ||
| 1 month | -0.17% | ||
| 3 months | +32.79% | ||
| 6 months | -11.94% | ||
| Current year | -11.55% |
| 1 week | 67.26 | 70 | |
| 1 month | 66.61 | 73.69 | |
| Current year | 46.1 | 80.08 | |
| 1 year | 46.1 | 105.9 | |
| 3 years | 46.1 | 144.5 | |
| 5 years | 46.1 | 144.5 | |
| 10 years | 11 | 144.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paresh Chawla
CEO | Chief Executive Officer | - | 2016-05-27 |
Bakulesh C. Shah
DFI | Director of Finance/CFO | 65 | - |
Yashoda Patidar
CMP | Compliance Officer | - | 2026-04-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 83 | - | |
Pravin C. Shah
BRD | Director/Board Member | 77 | 1966-12-31 |
Paresh Chawla
BRD | Director/Board Member | - | 2016-05-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.54% | +0.32% | -32.86% | -2.46% | 15.19M | ||
| +1.81% | +2.25% | +13.63% | +81.62% | 48B | ||
| -2.54% | +3.72% | +66.86% | +116.52% | 36.89B | ||
| +0.15% | +1.26% | -3.64% | +44.11% | 12.37B | ||
| +3.71% | +3.56% | +13.95% | +98.68% | 11.95B | ||
| +0.39% | +0.58% | +32.90% | +120.94% | 9.01B | ||
| +0.66% | -0.57% | +19.74% | +46.69% | 7.2B | ||
| +0.71% | +1.75% | +52.67% | -6.28% | 7.05B | ||
| +9.99% | +32.94% | -15.50% | +25.64% | 6.58B | ||
| +0.68% | +2.63% | +20.79% | +240.34% | 6.55B | ||
| Average | +1.50% | +3.85% | +16.86% | +76.58% | 14.56B | |
| Weighted average by Cap. | +0.84% | +3.35% | +28.06% | +89.73% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.09B 11.42M 9.98M 9.18M 8.55M 16.22M 16.47M 110M 42.82M 535M 42.87M 41.95M 1.84B | 1.12B 11.81M 10.32M 9.49M 8.84M 16.78M 17.03M 114M 44.28M 553M 44.33M 43.38M 1.9B |
| Net income | 168M 1.76M 1.54M 1.42M 1.32M 2.5M 2.54M 16.99M 6.61M 82.47M 6.61M 6.47M 284M | 195M 2.05M 1.79M 1.65M 1.53M 2.91M 2.95M 19.76M 7.68M 95.87M 7.69M 7.52M 330M |
| Net Debt | -876M -9.2M -8.04M -7.39M -6.89M -13.07M -13.27M -88.74M -34.5M -431M -34.54M -33.8M -1.48B | -1.13B -11.83M -10.35M -9.51M -8.86M -16.81M -17.06M -114M -44.37M -554M -44.42M -43.47M -1.91B |
Employees
453
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | ₹68.72 | -0.54% | 5,100 |
| 26-07-02 | ₹69.09 | +0.29% | 6,161 |
| 26-07-01 | ₹68.89 | +1.98% | 20,282 |
| 26-06-30 | ₹67.55 | -0.69% | 6,085 |
| 26-06-29 | ₹68.02 | -0.70% | 8,920 |
- Stock Market
- Stocks
- ALPA Stock
Select your edition
All financial news and data tailored to specific country editions
















